BICTF Biocure Technology Inc

USD 0.07 0.00 0
Icon

Biocure Technology Inc (BICTF) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.07000000000000001

0.00 (0.00)%

USD 6.58M

N/A

N/A

N/A

Icon

BICTF

Biocure Technology Inc (USD)
COMMON STOCK | OTC
USD 0.07
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 6.58M

N/A

USD 0.07

Biocure Technology Inc (BICTF) Stock Forecast

N/A

Based on the Biocure Technology Inc stock forecast from 0 analysts, the average analyst target price for Biocure Technology Inc is not available over the next 12 months. Biocure Technology Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biocure Technology Inc is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Biocure Technology Inc’s stock price was USD 0.07000000000000001. Biocure Technology Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +363.58% over the last year.

No recent analyst target price found for Biocure Technology Inc
No recent average analyst rating found for Biocure Technology Inc

Company Overview Biocure Technology Inc

Biocure Technology Inc., together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab. The company is developing Interferons-ß for the treatment of multiple sclerosis; Ranibizumab, a monoclonal anti...Read More

https://www.biocuretech.com

1055 West Hastings Street, Vancouver, BC, Canada, V6E 2E9

0

December

USD

USA

Adjusted Closing Price for Biocure Technology Inc (BICTF)

Loading...

Unadjusted Closing Price for Biocure Technology Inc (BICTF)

Loading...

Share Trading Volume for Biocure Technology Inc Shares

Loading...

Compare Performance of Biocure Technology Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BICTF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biocure Technology Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S +1.41 (+1.15%) USD564.56B 46.25 4.92

ETFs Containing BICTF

Symbol Name BICTF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biocure Technology Inc (BICTF) Stock

Stock Target Advisor's fundamental analysis for Biocure Technology Inc's stock is Slightly Bearish.

Unfortunately we do not have enough data on BICTF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BICTF's stock to indicate what its average analyst target is.

BICTF stock's Price/Earning ratio is 7.00. Our analysis grades BICTF stock's Price / Earning ratio at D. This means that BICTF stock's Price/Earning ratio is above 37% of the stocks in the Biotechnology sector in the OTC exchange. Based on this BICTF may be fairly valued for its sector

The last closing price of BICTF's stock was USD 0.07.

The most recent market capitalization for BICTF is USD 6.58M.

Unfortunately we do not have enough analyst data on BICTF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Biocure Technology Inc's stock.

As per our most recent records Biocure Technology Inc has 0 Employees.

Biocure Technology Inc's registered address is 1055 West Hastings Street, Vancouver, BC, Canada, V6E 2E9. You can get more information about it from Biocure Technology Inc's website at https://www.biocuretech.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...